Volume | 32,800 |
|
|||||
News | - | ||||||
Day High | 2.245 | Low High |
|||||
Day Low | 2.085 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Vivos Therapeutics Inc | VVOS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
2.20 | 2.085 | 2.245 | 2.13 | 2.20 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
231 | 32,800 | US$ 2.18 | US$ 71,555 | - | 1.9601 - 48.79 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:44:27 | formt | 300 | US$ 2.12 | USD |
Vivos Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.55M | 1.20M | - | 13.8M | -13.58M | -11.35 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Vivos Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VVOS Price Data
Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.13 | 2.34 | 2.06 | 2.22 | 44,921 | -0.01 | -0.47% |
1 Month | 2.57 | 2.72 | 1.9601 | 2.35 | 72,391 | -0.45 | -17.51% |
3 Months | 4.86 | 6.23 | 1.9601 | 3.11 | 181,393 | -2.74 | -56.38% |
6 Months | 4.99 | 48.79 | 1.9601 | 28.94 | 632,191 | -2.87 | -57.52% |
1 Year | 8.53 | 48.79 | 1.9601 | 11.48 | 1,897,238 | -6.41 | -75.15% |
3 Years | 140.75 | 177.25 | 1.9601 | 50.41 | 1,374,670 | -138.63 | -98.49% |
5 Years | 176.75 | 360.25 | 1.9601 | 56.68 | 1,246,153 | -174.63 | -98.80% |
Vivos Therapeutics Description
Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have been used to treat over 15,000 patients worldwide by more than 1,100 trained dentists. |